Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis

OBJECTIVE: To explore the safety and effectiveness of high-dose cyclophosphamide (HiCy) without bone marrow transplantation in patients with aggressive multiple sclerosis (MS). DESIGN: A 2-year open-label trial of patients with aggressive relapsing-remitting multiple sclerosis (RRMS) given an immuno...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Krishnan, Chitra, Kaplin, Adam I., Brodsky, Robert A., Drachman, Daniel B., Jones, Richard J., Pham, Dzung L., Richert, Nancy D., Pardo, Carlos A., Yousem, David M., Hammond, Edward, Quigg, Megan, Trecker, Carrilin, McArthur, Justin C., Nath, Avindra, Greenberg, Benjamin M., Calabresi, Peter A., Kerr, Douglas A.
Format: Artigo
Jezik:Inglês
Izdano: 2008
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2574697/
https://ncbi.nlm.nih.gov/pubmed/18541787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/archneurol.65.8.noc80042
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items